Shows / Targeted Talks
Targeted Talks
Targeted Talks is a podcast series from Targeted Oncology featuring one-on-one conversations with leading oncologists about the issues shaping cancer care today. Each episode explores the real-world challenges clinicians face alongside discussions of emerging research across tumor types. Whether unpacking new data, translating conference highlights into clinical context, or addressing the practical realities of oncology practice, Targeted Talks delivers timely, actionable conversations designed…
Episodes
- Targeted Talks
S8 Ep11: The Patients Missing From Breast Cancer Data
A single label can hide a lot. In this episode of Targeted Talks, two researchers look at what broad racial and ethnic categories obscure in breast cancer…
- Targeted Talks
S8 Ep10: Beyond the Scan: Predicting Immunotherapy Response With ctDNA in NSCLC
Valsamo “Elsa” Anagnostou, MD, PhD, of Johns Hopkins University School of Medicine, joins Targeted Talks to discuss a study on landmark circulating tumor DNA…
- Targeted Talks
S8 Ep9: Dr Bazhenova on the Updated FDA Label for Taletrectinib in ROS1+ NSCLC
On this episode of Targeted Talks, Lyudmila Bazhenova, MD, discusses the FDA’s expanded label approval of taletrectinib (Ibtrozi) for ROS1-positive non–small…
- Targeted Talks
S8 Ep8: Lung Cancer in Hispanic and Latinx Patients: Risk Factors, Biomarkers, and Clinical Trial Access
In this episode of Targeted Talks, recorded for Hispanic Heritage Month, Narjust Florez, MD, of Dana-Farber Cancer Institute, explains what oncologists should…
- Targeted Talks
S8 Ep7: Dr Jhaveri on the FDA Approval of Imlunestrant Plus Abemaciclib for ESR1-Mutated Breast Cancer
Komal Jhaveri, MD, joins Targeted Talks to discuss the FDA approval of imlunestrant (Inluriyo) in combination with abemaciclib (Verzenio) for patients with…
- Targeted Talks
S8 Ep6: Dr Herzberg on the Expanding Toolkit in KRAS-Mutant Non–Small Cell Lung Cancer
In this episode of Targeted Talks, Benjamin Herzberg, MD, discusses the evolving treatment landscape for KRAS-mutant non–small cell lung cancer (NSCLC). He…
- Targeted Talks
S8 Ep5: ASTRO 2026 Preview: Dr Raj Singh on De-Escalation, Brain Metastases, and What's Next in Radiation Oncology
Ahead of the 2026 ASTRO Annual Meeting, Dr Raj Singh of Baptist Health joins the podcast to break down the studies he's watching most closely. The conversation…
- Targeted Talks
S8 Ep4: Bringing CAR T and Bispecifics to the Community
Andrew Dalovisio, MD, a hematologist/oncologist at Mary Bird Perkins Cancer Center in Baton Rouge, Louisiana, discusses how his community cancer center built a…
- Targeted Talks
S8 Ep3: Rethinking HER2: A Pan-Cancer Look at IHC, ERBB2, and Tumor-Agnostic Testing
HER2 has long been synonymous with breast cancer, but a growing body of evidence shows it's expressed, at some level, across nearly every solid tumor type. In…
- Targeted Talks
S8 Ep2: Radiation Oncology's Financial Squeeze with Dr Ryan Funk
In this episode of Targeted Talks, Sabrina Serani speaks with Dr Ryan Funk, chief radiation oncology officer at The US Oncology Network and a radiation…
- Targeted Talks
S8 Ep1: Gynecologic Cancer Trends, Testing, and Treatment Advances Explained
Gynecologic cancer incidence is moving in 3 different directions at once, and clinicians outside gynecologic oncology are often the first to see the warning…
- Targeted Talks
S7 Ep19: AI in Oncology: Managing Information Overload for Trainees and Patients
In part 2 of this conversation, oncologists discuss how they help both patients and trainees navigate an overwhelming volume of medical information. The…
- Targeted Talks
S7 Ep18: Drowning in Data: How Oncologists Are Coping with Information Overload in the AI Era
In this episode of Treating Together, host Dr Pallav Mehta sits down with Dr Kurt Demel and Dr Yan Ji, 2 community-based medical oncologists practicing in the…
- Targeted Talks
S7 Ep17: Navigating the 505(b)(2) Pathway: Operational, Clinical, and Economic Strategies for Oncology Practices
In this episode, managing editor Sabrina Serani sits down with 3 experts at the intersection of oncology pharmacy, health informatics, and drug distribution to…
- Targeted Talks
S7 Ep16: ASCO 2026 Preview: Late-Breaking Abstracts Poised to Reshape the Treatment Landscape
Ahead of the 2026 ASCO Annual Meeting, Sabrina Serani, managing editor of Targeted Oncology, previews the late-breaking abstracts most likely to influence…
Targeted TalksS7 Ep15: Pediatric Blood Cancers: Building Better Outcomes Through Bold Science
In this episode of the Treating Together podcast, host Pallav Mehta, MD, medical oncologist at MD Anderson Cancer Center at Cooper University Health Care and…
Targeted TalksS7 Ep14: Choosing Wisely in CLL: A Deep Dive Into Frontline Treatment
In this episode of Treating Together, host Marc Braunstein, MD, PhD, associate professor of medicine at the NYU Perlmutter Cancer Center, sits down with Adam…
Targeted TalksS7 Ep13: Leveraging AI, Social Media, and Virtual Care in the Information Age
In this episode of Targeted Oncology’s Treating Together podcast, Dr Pallav Mehta sits down with Dr Sanjay Juneja, aka The Onc Doc, a medical oncologist known…
- Targeted Talks
S7 Ep11: Treating Together: Navigating Treatment Decisions in Relapsed NPM1-Mutant AML: Practical Insights for Clinical Care
Dr Gabriel Mannis from Stanford University and Dr Gail Roboz from Weill Cornell Medicine discussed the evolving treatment landscape for relapsed/refractory…
Targeted TalksS7 Ep10: Beyond the Hospital Walls: Expanding Access to Complex Cancer Therapies
In this episode of the Treating Together podcast, host Dr Pallav Mehta, medical oncologist at MD Anderson Cancer Center at Cooper, assistant professor of…
Targeted TalksS7 Ep9: Test First, Treat Second: ASCO's Updated Approach to Driver Mutation–Negative NSCLC
In this minisode, we break down the latest update to ASCO's living guideline for stage IV non–small cell lung cancer (NSCLC) without driver mutations — and…
Targeted TalksS7 Ep8: Precision Hope: The New Frontier of AI-Driven Oncology
Host Pallav Mehta, MD, and guest Doug Flora, MD discuss the use of artificial intelligence (AI) in oncology. As the author of Rebooting Cancer Care, Flora…
Targeted TalksS7 Ep7: Community Oncology at a Crossroads: Navigating Policy, Progress, and Practice
In this episode of Treating Together, host Pallav Mehta, MD, medical oncologist and director of Integrative Oncology at Cooper University Health Care and…
Targeted TalksS7 Ep6: Navigating the Future of CLL Care
In this episode of Treating Together, host Marc Braunstein, MD, an associate professor of medicine at the Perlmutter Cancer Center, NYU Grossman School of…
Targeted TalksS7 Ep5: Supporting Community Oncologists in a GU Research Era with Dr. Park, Dr. Garmezy, and Dr. Bupathi
This episode of Treating Together, hosted by Chandler Park, MD, featuring guests Benjamin Garmezy, MD, and Manoj Bupathi, MD, centers on the intersection of…
Targeted TalksS7 Ep3: Experts Delve Into Organ Preservation for Genitourinary Cancers
Benjamin Garmezy, MD, and Alexander Kenigsberg, MD, discuss strategies for preserving organs in GU cancers in the Treating Together podcast.
- Targeted Talks
S7 Ep2: Navigating Modern Lung Cancer Treatment and Clinical Trial Access
Edward S. Kim, MD, MBA, and Neel Shah, MD, discuss advancing lung cancer care and tackling real-world access barriers for community physicians.
- Targeted Talks
S7 Ep1: Advancing Prostate Cancer Treatment With Shared Decision-Making
In our first episode of Treating Together, Benjamin Garmezy, MD, and Ralph J. Miller Jr, MD, discuss multidisciplinary prostate cancer care.
Targeted TalksS6 Ep5: Predicting Palbociclib Outcomes in Breast Cancer Using Deep Learning
In this episode of Emerging Experts, Xiaojie Zhang, MD, a hematology/oncology fellow, and Akshat Singhal, PhD, a postdoctoral scholar, both at UC San Diego…
Targeted TalksS6 Ep4: BMT CTN 1902 in Myeloma: Key Findings With Garfall
In this episode of Targeted Talks, Alfred L. Garfall, MD, discusses the phase 2 BMT CTN 1902 trial (NCT05032820) of idecabtagene vicleucel (ide-cel; Abecma), a…
Targeted TalksS6 Ep3: Exploring Innovations in Lymphoma Treatment With Russler-Germain
David A. Russler-Germain, MD, PhD, physician-scientist at Washington University School of Medicine and Siteman Cancer Center, discusses his path in oncology…
Targeted TalksS6 Ep2: Behind the FDA Approval of Dato-DXd in HR+/HER2– Breast Cancer With Bardia
In this episode of Targeted Talks, Aditya Bardia, MD, MPH, FASCO, discusses the recent FDA approval of datopotamab deruxtecan for the treatment of patients…
Targeted TalksS6 Ep1: Juneja Explores AI’s Impact in Early Cancer Detection and Treatment
In this episode of Targeted Talks, Sanjay K. Juneja, MD, hematologist & medical oncologist at Mary Bird Perkins Cancer Center, discusses the exciting…
Targeted TalksS5 Ep20: How AI Is Revolutionizing Oncology in Diagnosis, Treatment, and Research
In this episode of Targeted Talks, Douglas Flora, MD, LSSBB, FACCC, executive medical director of oncology services at St. Elizabeth Healthcare, discusses the…
Targeted TalksS5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander
In this episode of Targeted Talks, Seth Wander, MD, PhD, medical oncologist at Massachusetts General Hospital and assistant professor at Harvard Medical…
Targeted TalksS5 Ep18: Turning Inspiration Into Innovation: Hazim’s Impact on Oncology
Antonious Hazim, MD, hematology medical oncology fellow at Mayo Clinic, Rochester, Minnesota, shares insights on his journey into oncology, his experiences at…
Targeted TalksS5 Ep17: Kaklamani's Insights on EMERALD Trial and Elacestrant in Advanced Breast Cancer
In this episode of Targeted Talks, Virginia Kaklamani, MD, DSc, professor of medicine in the Division of Hematology-Medical Oncology at The University of Texas…
Targeted TalksS5 Ep16: Foran Goes Beyond the Basics of BPDCN
In this episode of Targeted Talks, James M. Foran, MD, discusses the presentation and diagnosis of blastic plasmacytoid dendritic cell neoplasm.
Targeted TalksS5 Ep15: Tarantino Covers HER2-Low Breast Cancer and Antibody-Drug Conjugates
In this episode of Emerging Experts, Paolo Tarantino, MD, researcher at the European Institute of Oncology, and clinical research fellow at Dana-Farber Cancer…
Targeted TalksS5 Ep14: Breaking New Ground in Synovial Sarcoma: Choy on the FDA Approval of Afami-cel
In this episode of Targeted Talks, Edwin Choy, MD, PhD, discussed the FDA approval of afamitresgene autoleucel for the treatment of patients with advanced…
Targeted TalksS5 Ep13: Cancer Research Across Continents: Fujiwara’s Path From Japan to the US
In this episode of Emerging Experts, Yu Fujiwara, shares his journey from Japan to the United States and his path to becoming a specialist in hematology and…
Targeted TalksS5 Ep12: Advancing Melanoma Treatment: Hamid on Lifileucel's Role
In this episode of Targeted Talks, Omid Hamid, MD, discusses data supporting the use of lifileucel for the treatment of advanced melanoma.
Targeted TalksS5 Ep11: Transforming Prostate Cancer Care Through Personalized Medicine
Adam Weiner, MD, discusses his journey toward becoming an oncologist with a focus in urology in this episode of Emerging Experts.
Targeted TalksS5 Ep10: Dhakal Reflects on the FDA Approval of Cilta-Cel for Earlier Lines of RRMM
In this episode of Targeted Talks, Binod Dhakal, MD, MS, discusses the recent FDA approval of ciltacabtagene autoleucel for the treatment of…
Targeted TalksS5 Ep9: Unlocking the Potential of Technology in Community Oncology
In this episode of Targeted Talks, Nini Wu, MD, MBA, chief medical and development officer at Cardinal Health, shares her insights on the ever-changing world…
Targeted TalksS5 Ep8: LaPelusa’s Journey in the Dynamic Field of GI Oncology
In the latest episode of Emerging Experts, Michael LaPelusa, MD, hematology and oncology fellow at MD Anderson Cancer Center, shares his insights, experiences…
Targeted TalksS5 Ep7: The Future of Breast Cancer Care: Blackwood on Personalized Approaches
In this episode of Targeted Talks, M. Michele Blackwood, MD, FACS, director of breast surgery, Robert Wood Johnson (RWJ), Barnabas Health, director of women’s…
Targeted TalksS5 Ep6: Dizman’s Global Pursuit to Cancer Research and Understanding
In this episode of Emerging Experts, Nazli Dizman, MD, shares the intricacies of her journey towards becoming an oncologist in the United States.
Targeted TalksS5 Ep5: FDA Approval Marks Amivantamab's Milestone in EGFR+ NSCLC
In this episode, Joshua K. Sabari, MD, discusses the FDA approval of amivantamab plus chemotherapy as a first-line treatment for patients with EGFR exon 20…
Targeted TalksS5 Ep4: Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC
In this episode of Emerging Experts, Peter Zang, MD, highlights research on baseline CD8 lymph node avidity with 89-Zr-crefmirlimab for the treatment of…
Targeted TalksS5 Ep3: Advancing Myeloma Treatment With Blood-Based MRD Testing
In season 5, episode 3 of Targeted Talks, Ben Derman, MD, assistant professor of medicine at the University of Chicago Medical Center, dissects the latest…
Targeted TalksS5 Ep2: Beyond the First-Line: Economides on Advancing Therapies in RCC
In our 4th episode of Emerging Experts, Minas P. Economides, MD, assistant professor of medicine at NYU Langone Perlmutter Cancer Center, unveils the…
Targeted TalksS5 Ep1: A Deep Dive Into the Evolving Landscape of Prostate Cancer
In season 5, episode 1 of Targeted Talks, Badrinath Konety, MD, president of the Allina Health Cancer Institute and the chief academic officer for Allina…
Targeted TalksS4 Ep20: Lisberg Discusses Dato-DXd's Role in Advanced Lung Cancer Care
In season 4, episode 20 of Targeted Talks, Aaron Lisberg, MD, a thoracic medical oncologist at the University of California, Los Angeles, delves into findings…
Targeted TalksS4 Ep19: Navigating the Landscape of Immunotherapy Toxicities
In our third episode of Emerging Experts, host Jordyn Sava is joined by Matthew Hadfield, DO, a third-year hematology/oncology fellow at Brown University, to…
Targeted TalksS4 Ep18: Behind the FDA Approval of Fruquintinib for Previously Treated mCRC
In season 4, episode 18 of Targeted Talks, Arvind Dasari, MD, MS, dives into the recent approval of fruquintinib for patients with with metastatic colorectal…
Targeted TalksS4 Ep17: Bridging Science and Compassion in Cancer Care
In this episode of Emerging Experts, host Jordyn Sava is joined by Hemali Batra-Sharma, MD, fellow, Hematology/Oncology, University of California San Diego…
Targeted TalksS4 Ep16: Tailoring Treatments to Better Outcomes in Liver Cancer
In season 4, episode 16 of Targeted Talks, Susanne G. Warner, MD, hepatobiliary and pancreas surgeon at the Mayo Clinic in Rochester, Minnesota, discusses the…